From Guardian Web (February 5, 2013)
Ahead of its results on Wednesday, GlaxoSmithKline has
successfully raised its stake in its Indian consumer
subsidiary.
The company is paying £568m to take its shareholding in
the business – whose… (Source: Drugs.com – Pharma News)
Glaxosmithkline Raises Stake in Indian Business While Reckitt Shakes of suboxone worries
Previous post: Novel Opioid Dependence Pill Gets Patients' Thumbs-UpNovel Opioid Dependence Pill Gets Patients' Thumbs-Up